WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Sunday, September 18, 2016

MU scientists develop new approach for Parkinson’s disease therapy

September 18, 2016

Dr. Elmer Price is shown with researchers, from left Lydia Hager, Arrin Carter and Amanda Clark.


HUNTINGTON — Last year, Dr. Elmer Price, a professor of biological sciences at Marshall University, was awarded a three-year, $350,000 research grant from the National Science Foundation.
The grant funds his research into understanding neurogenesis, the process adult brains use to generate new neurons from preexisting adult neural stem cells. Price and his student researchers have now discovered a way to recruit these adult neural stem cells into regions of the brain which typically lack the ability to replenish neurons. Their findings have tremendous therapeutic potential for cases of neurodegenerative disorders like Parkinson’s disease, stroke or traumatic brain injury.
Price and researchers Amanda Clark, Arrin Carter and Lydia Hager have published their research in the Aug. 1 issue of the journal Stem Cells and Development.
Their discovery is based on the fact that the adult brain has its own supply of adult neural stem cells. These stem cells are only found in two specific regions of the adult brain. Price’s lab has developed a way to actually steer these neural stem cells away from their usual location and into a new region of the brain that typically is unable to regenerate new neurons.
They accomplished this by making small cylinders out of a mixture of biologically-compatible materials, and then surgically implanting these cylinders into the brain. Price’s study revealed that, over time, the adult neural stem cells used the cylindrical implant as a new pathway and subsequently migrated along this path into a new region of the brain.
The Marshall researchers also found that these cylinder implants reversed the Parkinson’s-like behavior in rats who had an experimentally-induced version of the disease, suggesting the neural cells that responded to the implant were able to replace neurons lost in Parkinson’s disease.
“We are pretty excited about this work for a number of reasons,” said Price. “It describes a totally new approach for treating neurodegenerative disorders such as Parkinson’s disease and we predict that this approach will also be useful in cases of stroke or traumatic brain injury; however, those studies have yet to be completed. This paper is the product of many years of work and hopefully is the first of a number of important findings regarding this unique approach. This is just the beginning of a long process; we are very, very far from moving this into humans but this paper is a critical first step.”
One key feature of Price’s approach is that the implants make use of the brain’s preexisting stem cells; once reduced to practice, a patient’s own neural stem cells would be harnessed for targeted brain repair.
http://www.fayettetribune.com/community/mu-scientists-develop-new-approach-for-parkinson-s-disease-therapy/article_0289a428-7d0b-11e6-ad76-fb7a1ee0bf38.html

No comments:

Post a Comment